Tryfonidis, Konstantinos
Marreaud, S.
Khaled, H.
De Valk, B.
Vermorken, J.
Welnicka-Jaskiewicz, M.
Aalders, K.
Bartlett, J. M. S.
Biganzoli, L.
Bogaerts, J.
Cameron, David
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study
https://doi.org/10.1007/s10549-017-4203-y
Article History
Received: 9 March 2017
Accepted: 13 March 2017
First Online: 21 March 2017
Compliance with Ethical Standard
:
: The authors declare none.